Terms: = Leukemia AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Diagnosis
91 results:
1. Clinical Risks for Chronic Lymphocytic leukemia.
Brown JR
J Natl Compr Canc Netw; 2024 Apr; 22(3):. PubMed ID: 38626793
[TBL] [Abstract] [Full Text] [Related]
2. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
3. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
[No Abstract] [Full Text] [Related]
4. Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes.
Matsuo T; Wurster S; Jiang Y; Sasaki K; Tarrand J; Lewis RE; Kontoyiannis DP
J Antimicrob Chemother; 2024 Feb; 79(2):297-306. PubMed ID: 38073151
[TBL] [Abstract] [Full Text] [Related]
5. Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.
Karolová J; Kazantsev D; Svatoň M; Tušková L; Forsterová K; Maláriková D; Benešová K; Heizer T; Dolníková A; Klánová M; Winkovska L; Svobodová K; Hojný J; Krkavcová E; Froňková E; Zemanová Z; Trněný M; Klener P
Am J Hematol; 2023 Oct; 98(10):1627-1636. PubMed ID: 37605345
[TBL] [Abstract] [Full Text] [Related]
6. Opportunistic genetic screening increases the diagnostic yield and is medically valuable for care of patients and their relatives with hereditary cancer.
Fernández-Castillejo S; Roig B; Melé M; Serrano S; Salvat M; Querol M; Brunet J; Pineda M; Cisneros A; Parada D; Badia J; Borràs J; Rodríguez-Balada M; Gumà J
J Med Genet; 2023 Dec; 61(1):69-77. PubMed ID: 37591735
[TBL] [Abstract] [Full Text] [Related]
7. T-Cell Prolymphocytic leukemia: diagnosis, Pathogenesis, and Treatment.
Gutierrez M; Bladek P; Goksu B; Murga-Zamalloa C; Bixby D; Wilcox R
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569479
[TBL] [Abstract] [Full Text] [Related]
8. Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma.
El Hussein S; Medeiros LJ; Lyapichev KA; Fang H; Jelloul FZ; Fiskus W; Chen J; Wei P; Schlette E; Xu J; Li S; Kanagal-Shamanna R; Yang H; Tang Z; Thakral B; Loghavi S; Jain N; Thompson PA; Ferrajoli A; Wierda WG; Jabbour E; Patel KP; Dabaja BS; Bhalla KN; Khoury JD
Pathology; 2023 Jun; 55(4):514-524. PubMed ID: 36933995
[TBL] [Abstract] [Full Text] [Related]
9. Recurrent germline variant in atm associated with familial myeloproliferative neoplasms.
Braunstein EM; Imada E; Pasca S; Wang S; Chen H; Alba C; Hupalo DN; Wilkerson M; Dalgard CL; Ghannam J; Liu Y; Marchionni L; Moliterno A; Hourigan CS; Gondek LP
Leukemia; 2023 Mar; 37(3):627-635. PubMed ID: 36543879
[TBL] [Abstract] [Full Text] [Related]
10. Rare Germline
Lampson BL; Gupta A; Tyekucheva S; Mashima K; Petráčková A; Wang Z; Wojciechowska N; Shaughnessy CJ; Baker PO; Fernandes SM; Shupe S; Machado JH; Fardoun R; Kim AS; Brown JR
J Clin Oncol; 2023 Feb; 41(5):1116-1128. PubMed ID: 36315919
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine.
Döhner H; Wei AH; Roboz GJ; Montesinos P; Thol FR; Ravandi F; Dombret H; Porkka K; Sandhu I; Skikne B; See WL; Ugidos M; Risueño A; Chan ET; Thakurta A; Beach CL; Lopes de Menezes D
Blood; 2022 Oct; 140(15):1674-1685. PubMed ID: 35960871
[TBL] [Abstract] [Full Text] [Related]
12. Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
Favini C; Talotta D; Almasri M; Andorno A; Rasi S; Adhinaveni R; Kogila S; Awikeh B; Schipani M; Boggione P; Mouhssine S; Ghanej J; Al Essa W; Mahmoud AM; Dondolin R; Alessa N; Margiotta Casaluci G; Boldorini R; Gattei V; Gaidano G; Moia R
Br J Haematol; 2022 Sep; 198(6):1016-1022. PubMed ID: 35829664
[TBL] [Abstract] [Full Text] [Related]
13. [Analysis of Agranulocytosis Time and Its Influencing Factors in Patients with Hematological Malignancies Treated with rhIL-11 combined rhG-CSF].
Wei HM; Li ZJ; Wang LN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):930-936. PubMed ID: 35680829
[TBL] [Abstract] [Full Text] [Related]
14. Identification of seasonal variation in the diagnosis of acute myeloid leukaemia: a population-based study.
Sánchez-Vizcaíno F; Tamayo C; Ramos F; Láinez-González D; Serrano-López J; Barba R; Martin MD; Llamas P; Alonso-Dominguez JM
Br J Haematol; 2022 Aug; 198(3):545-555. PubMed ID: 35639095
[TBL] [Abstract] [Full Text] [Related]
15. Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases.
Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
[TBL] [Abstract] [Full Text] [Related]
16. Looking Back to Move Forward: Lessons Learned from a Successful, Sustainable, Replicable Model of Adolescent and Young Adult Program of a Tertiary Cancer Care Center.
Pitch N; Stefaniuk S; MacMillan M; Catsburg J; Gupta AA; Vora T
J Adolesc Young Adult Oncol; 2022 Apr; 11(2):181-188. PubMed ID: 35007440
[No Abstract] [Full Text] [Related]
17. The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19.
Li A; Kuderer NM; Hsu CY; Shyr Y; Warner JL; Shah DP; Kumar V; Shah S; Kulkarni AA; Fu J; Gulati S; Zon RL; Li M; Desai A; Egan PC; Bakouny Z; Kc D; Hwang C; Akpan IJ; McKay RR; Girard J; Schmidt AL; Halmos B; Thompson MA; Patel JM; Pennell NA; Peters S; Elshoury A; de Lima Lopes G; Stover DG; Grivas P; Rini BI; Painter CA; Mishra S; Connors JM; Lyman GH; Rosovsky RP;
J Thromb Haemost; 2021 Oct; 19(10):2522-2532. PubMed ID: 34260813
[TBL] [Abstract] [Full Text] [Related]
18. Discriminating leukemia Cellular Heterogeneity and Screening Metabolite Biomarker Candidates using Label-Free Mass Cytometry.
Yao H; Zhao H; Pan X; Zhao X; Feng J; Yang C; Zhang S; Zhang X
Anal Chem; 2021 Jul; 93(29):10282-10291. PubMed ID: 34259005
[TBL] [Abstract] [Full Text] [Related]
19. Real-world Prescription Pattern, Discontinuation and Costs of Ibrutinib-Naïve Patients with Chronic Lymphocytic leukemia: An Italian Healthcare Administrative Database Analysis.
Ronconi G; Dondi L; Calabria S; Piccinni C; Pedrini A; Esposito I; Martini N
Clin Drug Investig; 2021 Jul; 41(7):595-604. PubMed ID: 34032988
[TBL] [Abstract] [Full Text] [Related]
20. What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms.
Voso MT; Falconi G; Fabiani E
Blood; 2021 Sep; 138(9):749-757. PubMed ID: 33876223
[TBL] [Abstract] [Full Text] [Related]
[Next]
